Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience

被引:14
|
作者
De-la-Cruz-Ku, Gabriel [1 ]
Luyo, Marianne [2 ]
Morante, Zaida [3 ]
Enriquez, Daniel [3 ]
Moller, Mecker G. [4 ]
Chambergo-Michilot, Diego [1 ,5 ]
Flores, Lucero [1 ]
Luque, Renato [1 ,6 ]
Saavedra, Antonella [1 ,6 ]
Eyzaguirre-Sandoval, Miguel E. [1 ,6 ]
Lujan-Peche, Maria G. [1 ,6 ]
Noel, Naysha [1 ]
Calderon, Hafid [1 ,6 ]
Razuri, Cesar [7 ]
Fuentes, Hugo A. [3 ]
Manuel Cotrina, Jose [3 ]
Neciosup, Silvia P. [3 ]
Araujo, Jhajaira [8 ]
Lema, Alexandra [9 ]
Pinto, Joseph [8 ]
Gomez, Henry L. [3 ]
Valcarcel, Bryan [10 ]
机构
[1] Univ Cient Sur UCSUR, Sch Med, Lima, Peru
[2] Univ Peruana Cayetano Heredia, Lima, Peru
[3] Inst Nacl Enfermedades Neoplas, Lima, Peru
[4] Univ Miami, Miller Sch Med, Div Surg Oncol, Jackson Mem Hosp,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[5] Tau RELAPED Grp, Trujillo, Peru
[6] Soc Cient Estudiantes Med Humana SCIEM UCSUR, Lima, Peru
[7] Hosp Nacl Mayo, Lima, Peru
[8] Oncosalud AUNA, Unidad Invest Basica & Translac, Lima, Peru
[9] Univ Cuenca, Hlth Sci Fac, Cuenca, Ecuador
[10] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA
来源
PLOS ONE | 2020年 / 15卷 / 08期
关键词
FAMILY-HISTORY; SURVIVAL; WOMEN; PROGNOSIS; SUBTYPES; IMPACT; ASSOCIATION; RECURRENCE; MASTECTOMY; OUTCOMES;
D O I
10.1371/journal.pone.0237811
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. Methods We reviewed the medical records of new cases treated at a single institution in the period 2000-2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. Results Among the 2007 patients included, the median age at diagnosis was 49 years (19-95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05-3.15) and mortality (HR: 2.51, 95% CI: 2.01-3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. Conclusion The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] The prognostic impact of age in patients with triple-negative breast cancer
    Cornelia Liedtke
    K. R. Hess
    T. Karn
    A. Rody
    L. Kiesel
    G. N. Hortobagyi
    L. Pusztai
    A. M. Gonzalez-Angulo
    Breast Cancer Research and Treatment, 2013, 138 : 591 - 599
  • [22] The prognostic impact of age in patients with triple-negative breast cancer
    Liedtke, Cornelia
    Hess, K. R.
    Karn, T.
    Rody, A.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (02) : 591 - 599
  • [23] Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
    Guo, Lin-Wei
    Jiang, Lin-Miao
    Gong, Yue
    Zhang, Hong-Hua
    Li, Xiao-Guang
    He, Min
    Sun, Wei-Li
    Ling, Hong
    Hu, Xin
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5881 - 5894
  • [24] Triple-negative breast cancer
    Chacon, Reinaldo D.
    Costanzo, Maria V.
    BREAST CANCER RESEARCH, 2010, 12
  • [25] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Michel, Laura L.
    von Au, Alexandra
    Mavratzas, Athanasios
    Smetanay, Katharina
    Schuetz, Florian
    Schneeweiss, Andreas
    TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
  • [26] Association of statin use with clinical outcomes in patients with triple-negative breast cancer
    Nowakowska, Malgorzata K.
    Lei, Xiudong
    Thompson, Mikayla T.
    Shaitelman, Simona F.
    Wehner, Mackenzie R.
    Woodward, Wendy A.
    Giordano, Sharon H.
    Nead, Kevin T.
    CANCER, 2021, 127 (22) : 4142 - 4150
  • [27] Medullary breast cancer is a predominantly triple-negative breast cancer - histopathological analysis and comparison with invasive ductal breast cancer
    Budzik, Michal
    Sobieraj, Maciej
    Sobol, Maria
    Patera, Janusz
    Czerw, Aleksandra
    Deptala, Andrzej
    Badowska-Kozakiewicz, Anna
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (02) : 432 - 439
  • [28] A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns
    Tzikas, Anna-Karin
    Nemes, Szilard
    Linderholm, Barbro K.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (03) : 643 - 654
  • [29] Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma
    Jing, Na
    Ma, Ming-Wei
    Gao, Xian-Shu
    Liu, Jian-Ting
    Gu, Xiao-Bin
    Zhang, Min
    Zhao, Bo
    Wang, Yu
    Wang, Xian-Ling
    Jia, Hai-Xia
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [30] Impact of Body Mass Index on Clinical Outcomes in Triple-Negative Breast Cancer
    Ademuyiwa, Foluso O.
    Groman, Adrienne
    O'Connor, Tracey
    Ambrosone, Christine
    Watroba, Nancy
    Edge, Stephen B.
    CANCER, 2011, 117 (18) : 4132 - 4140